Maisi David Cabral
São Paulo, 01504-001, Brazil
NCT Number: NCT02939625
Asthma is characterized by recurrent episodes of bronchospasm, bronchial hyperresponsiveness and chronic airway inflammation and pharmacological treatment for this condition is done with bronchodilators and anti-inflammatory.
Looking for future studies?
Notify Me5 year–11 year
All sexes
Interventional
Not applicable
São Paulo, 01504-001, Brazil
Pharmacologic therapy has clinical efficacy in the control, but the patient often does not adhere adequately.
There is need for further research into non-pharmacological therapies for clinical asthma control and in turn the use of CPAP and bilevel pressure in the airways has shown beneficial effects on autonomic modulation and bronchial responsiveness leading to the hypothesis that these therapies also have effects on the BIE.The aim of this study is to evaluate the effect of these non-pharmacological therapies in several variables and especially the BIE.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 5 minutes
assess the degree of inflammation of the respiratory system using expired fraction of nitric oxide before and after the different protocols applied
Time frame: 20 minutes
Time frame: 10 minutes
Time frame: 20 minutes
Time frame: 10 minutes
Time frame: 30 minutes
University of Nove de Julho
Other
Effects of Continuous and Bilevel Positive Airway Pressure During Exercise-induced Bronchoconstriction in Asthmatic Children: Controlled Clinical Trial, Randomized
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05850494
Asthma, Bronchial Diseases
North Dartmouth, Massachusetts, United States
View Trial DetailsNCT03000413
Asthma, Bronchial Diseases
Porto Alegre, Brazil
View Trial DetailsNCT04373499
Asthma, Bronchial Diseases
Chicago, Illinois, United States
View Trial DetailsNCT01188577
Asthma, Bronchial Diseases
Cypress, California, United States
View Trial Details